“…Moreover, he proposed that N/L can be utilized as a biomarker beyond fine needle aspiration cytology. Thereto, he highlighted N/L as being proven in distinguishing between benign and malignant nodules in patients 1 with suspicious thyroid nodules 1 , 5 – 17 . Nevertheless, at least a minimal debate is still ongoing on an accurate decision on N/L whether it is a biomarker in discrimination of malignity or not.…”